Positive effects of liraglutide as adjunct to insulin in type 1 diabetes: glycaemic control and safety in a randomised, double blind, placebo controlled crossover trial

被引：0
|
作者：
Heller, S. R. [1 ]
Korsatko, S. [2 ]
Gurban, J. [2 ]
Jensen, L. [3 ]
Christiansen, E. [3 ]
Kiyomi, F. [4 ]
Pieber, T. R. [2 ]
机构：
[1] Univ Sheffield, Sch Med, Sheffield S10 2TN, S Yorkshire, England
[2] Med Univ Graz, Graz, Austria
[3] Novo Nordisk AS, Soborg, Denmark
[4] Novo Nordisk Pharma Ltd, Tokyo, Japan
来源：
DIABETOLOGIA | 2013年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3
引用
收藏
页码：S7 / S8
页数：2
相关论文
共 50 条
  • [31] A randomised controlled trial to assess the antithrombotic effects of aspirin in type 1 diabetes: role of dosing and glycaemic control
    Parker, William A. E.
    Sagar, Rebecca
    Kurdee, Zeyad
    Hawkins, Fladia
    Naseem, Khalid M.
    Grant, Peter J.
    Storey, Robert F.
    Ajjan, Ramzi A.
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [32] Double-Blind, Placebo-Controlled, Randomised Trial to Assess the Effect of Liraglutide on Ectopic Fat Accumulation in Type 2 Diabetes Mellitus Patients
    Bizino, Maurice B.
    Jazet, Ingrid M.
    Lamb, Hildo J.
    Smit, Jan W.
    DIABETES, 2017, 66 : A63 - A64
  • [33] A randomised controlled trial to assess the antithrombotic effects of aspirin in type 1 diabetes: role of dosing and glycaemic control
    William A. E. Parker
    Rebecca Sagar
    Zeyad Kurdee
    Fladia Hawkins
    Khalid M. Naseem
    Peter J. Grant
    Robert F. Storey
    Ramzi A. Ajjan
    Cardiovascular Diabetology, 20
  • [34] Effects of telemonitoring on glycaemic control and healthcare costs in type 2 diabetes: A randomised controlled trial
    Warren, Robin
    Carlisle, Karen
    Mihala, Gabor
    Scuffham, Paul A.
    JOURNAL OF TELEMEDICINE AND TELECARE, 2018, 24 (09) : 586 - 595
  • [35] Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
    Astrup, Arne
    Rossner, Stephan
    Van Gaal, Luc
    Rissanen, Aila
    Niskanen, Leo
    Al Hakim, Mazin
    Madsen, Jesper
    Rasmussen, Mads F.
    Lean, Michael E. J.
    LANCET, 2009, 374 (9701): : 1606 - 1616
  • [36] Effects of liraglutide on cardiovascular risk biomarkers in patients with type 2 diabetes and albuminuria: A sub-analysis of a randomized, placebo-controlled, double-blind, crossover trial
    von Scholten, Bernt Johan
    Persson, Frederik
    Rosenlund, Signe
    Eugen-Olsen, Jesper
    Pielak, Tomasz
    Faber, Jens
    Hansen, Tine W.
    Rossing, Peter
    DIABETES OBESITY & METABOLISM, 2017, 19 (06): : 901 - 905
  • [37] A PLACEBO CONTROLLED, DOUBLE-BLIND, CROSSOVER TRIAL ON THE HEMORHEOLOGICAL EFFECTS OF MOLSEDOMIN
    ERNST, E
    MATRAI, A
    BIORHEOLOGY, 1986, 23 (03) : 296 - 296
  • [38] A randomised, double blind, placebo-controlled trial on the effect of Fusidin in patients with newly diagnosed Type 1 diabetes:: the FUSIDM trial
    Conget, I
    Aguilera, E
    Pellitero, S
    Näf, S
    Bendtzen, K
    Casamitjana, R
    Gomis, R
    Nicoletti, F
    DIABETOLOGIA, 2004, 47 : A293 - A293
  • [39] Effects of probiotic supplementation on glycaemic control and lipid profiles in gestational diabetes: A randomized, double-blind, placebo-controlled trial
    Karamali, M.
    Dadkhah, F.
    Sadrkhanlou, M.
    Jamilian, M.
    Ahmadi, S.
    Tajabadi-Ebrahimi, M.
    Jafari, P.
    Asemi, Z.
    DIABETES & METABOLISM, 2016, 42 (04) : 234 - 241
  • [40] Effects of different soy preparations on glycaemic control and cardiovascular disease risk in Type 2 diabetes: a randomised placebo-controlled double-blind parallel study
    Konya, J.
    Rigby, A.
    Sathyapalan, T.
    Kilpatrick, E. S.
    Atkin, S. L.
    DIABETIC MEDICINE, 2014, 31 : 63 - 64
12345